Research & Development

Grid Item Thumb
A new report by Boston Healthcare has analysed the limitations of FDA approval with regards to cancer drugs Read more
A recent study in STEM CELLS Translational Medicine could open the door to a new therapy Read more
Several factors have a direct influence on adherence. Read more
Theranos has received much praise along with a healthy dose of skepticism in recent months Read more
Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI Read more
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting Read more
In the first study of its kind, researchers have demonstrated novel and previously unknown mechanisms of action Read more
Dr. Rath Research Institute: Revolutionary new concept of heart disease threatens end of global statin market Read more